All ETFsIBB
IBB
iShares Biotechnology ETF
Tracks: Broad Market Benchmark IndexHedging: Unhedged
Medium to High RiskU.S. EquityTechnologyGrowth
RRSPTFSARESPFHSARDSP
Management Expense Ratio
0.22%
Annual fee
Dividend Yield
0.23%
Trailing 12-month
Distribution Frequency
Quarterly
Payout schedule
Assets Under Management
$7.9B
Total fund size
Investment Objective
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
STOP OVERPAYING
Still holding bank mutual funds?
The average Canadian bank mutual fund charges a 2.2% MER— that's over 20x more than IBB's fee. Switch to commission-free, self-directed investing and keep more of your returns. Open an account in minutes.
Affiliate disclosure: We may earn a commission at no cost to you.